Detalhe da pesquisa
1.
Longitudinal evaluation of major salivary gland functioning in Sjögren's disease patients in a prospective standard-of-care cohort.
Clin Exp Rheumatol
; 41(12): 2474-2483, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38149509
2.
Change in disease activity is associated with TNF-α inhibitor serum levels in patients with axial spondyloarthritis in daily clinical practice.
Clin Exp Rheumatol
; 40(3): 489-494, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34128804
3.
Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjögren's syndrome patients.
Clin Exp Rheumatol
; 40(12): 2338-2343, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36063118
4.
Selection of study endpoints and patients for clinical trials in primary Sjögren's syndrome.
Clin Exp Rheumatol
; 40(12): 2225-2232, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36305355
5.
Patient Acceptable Symptom State (PASS) in patients with primary Sjögren's syndrome in daily clinical practice.
Clin Exp Rheumatol
; 40(12): 2303-2309, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36441658
6.
Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome.
Clin Exp Rheumatol
; 40(12): 2290-2297, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36441656
7.
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren's syndrome.
Clin Exp Rheumatol
; 39 Suppl 133(6): 100-106, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34796851
8.
Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.
Clin Exp Rheumatol
; 39 Suppl 133(6): 73-79, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34665706
9.
Differences in presentation between paediatric- and adult-onset primary Sjögren's syndrome patients.
Clin Exp Rheumatol
; 39 Suppl 133(6): 85-92, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34796855
10.
Ten years of the ESSDAI: is it fit for purpose?
Clin Exp Rheumatol
; 38 Suppl 126(4): 283-290, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33095151
11.
Minimal added value of separate dryness assessments compared with overall dryness in ESSPRI in patients with Sjögren's disease.
Rheumatology (Oxford)
; 63(2): e29-e31, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37632773
12.
Correspondence on 'Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised controlled trial'.
Ann Rheum Dis
; 82(6): e148, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33757967
13.
Added value of the salivary gland ultrasonography OMERACT score in the ACR/EULAR classification criteria for Sjögren's disease.
Semin Arthritis Rheum
; 67: 152473, 2024 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38805898
14.
High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis.
Arthritis Res Ther
; 25(1): 202, 2023 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37848964
15.
Association of Circulating Antibody-Secreting Cell Maturity With Disease Features in Primary Sjögren's Syndrome.
Arthritis Rheumatol
; 75(6): 973-983, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36533856
16.
Why do drug treatments fail in Sjögren's disease? Considerations for treatment, trial design and interpretation of clinical efficacy.
Expert Rev Clin Immunol
; 19(10): 1187-1194, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37551702
17.
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS).
Arthritis Rheumatol
; 2023 Dec 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38073013
18.
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome.
RMD Open
; 8(1)2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35414631
19.
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial.
Semin Arthritis Rheum
; 53: 151955, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35091325
20.
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure.
Lancet Rheumatol
; 3(8): e553-e562, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-38287621